OakChart

Healthpeak Properties Inc

DOCReal Estate·REIT - Healthcare Facilities·USA·Large·NYSE·Nov 11 • 8:24 AM ET

20.41-0.00 (-0.02%)
2026-11-11 14:58 CET
Market cap
14,073.59 USD m
Revenue, TTM
3,064.82 USD m
Net income, TTM
377.12 USD m
Free cash flow, TTM
1,137.86 USD m
EPS diluted, TTM
0.54
P/E
37.56
Compare

Price

DOC against its 20, 50 and 200-day averages
2050200beatmiss
18.0020.0022.0031.0M61.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DOCclose 20.4120-day 19.4050-day 19.72200-day 19.2220.41

11.1% under 22.95 on 28 Jul 2026. Last 15 sessions, 13.5% high to low

Profile

DOC
52-week range, 65% of the way up
15.7022.95

Healthpeak Properties, Inc. engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Outpatient Medical, Lab, and Senior Housing. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The Lab segment consists of laboratory and office space. The Senior Housing segment includes life plan communities and unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in March 1985 and is headquartered in Denver, CO.

IndexS&P 500, RUI
Employees411
IPOJul 19, 2013
Beta0.97
ATR, 14d0.47
Rel volume0.00
Short float3.32%
Insider own0.31%
Inst own99.90%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap14.42B
Enterprise Value26.42B
Income377.12M
Sales3.06B
Book/sh11.41
Cash/sh0.86
Dividend Est.1.20 (5.87%)
Dividend TTM1.22 (6.00%)
Dividend Ex-DateNov 13, 2026
Dividend Gr. 3/5Y0.55% -3.79%
Payout1204.37%
Employees411
IPOJul 19, 2013

Ratios

P/E37.56
Forward P/E115.53
PEG3.07
P/S4.70
P/B1.79
P/C23.80
P/FCF12.67
EV/EBITDA16.00
EV/Sales8.62
Quick Ratio14.01
Current Ratio14.01
Debt/Eq1.23
LT Debt/Eq1.22
Option/ShortYes / Yes

Earnings

EPS (ttm)0.54
EPS next Y0.18
EPS next Q0.04
EPS this Y330.67%
EPS next Y-58.99%
EPS next 5Y37.64%
EPS past 3/5Y-52.08% -
Sales past 3/5Y11.05% 11.40%
EPS Y/Y TTM1063.30%
Sales Y/Y TTM9.42%
EPS Q/Q114.70%
Sales Q/Q16.29%
EarningsNov 02 AMC
EPS/Sales Surpr.-68.50% 10.08%

Ownership

Insider Own0.31%
Insider Trans-0.77%
Inst Own99.90%
Inst Trans-3.18%
ROA1.80%
ROE4.88%
ROIC2.16%
Gross Margin19.79%
Oper. Margin16.86%
Profit Margin12.30%
SMA205.15%
SMA503.46%
SMA2006.14%
Trades-

Technical

Shs Outstand689.54M
Shs Float687.40M
Short Float3.32%
Short Ratio4.18
Short Interest22.86M
52W High22.95 -11.09%
52W Low15.70 29.97%
Volatility2.69% 2.52%
ATR (14)0.47
RSI (14)61.44
Beta0.97
Rel Volume0.00
Avg Volume5.47M
Volume328

Performance

Perf Week1.17%
Perf Month7.51%
Perf Quarter-1.95%
Perf Half Y4.37%
Perf YTD26.90%
Perf Year13.99%
Perf 3Y31.14%
Perf 5Y-38.13%
Perf 10Y-24.75%
Recom2.36
Target Price22.41
Prev Close20.41
Price20.41
Change %-0.02%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 07, 2026InitiatedBBarclaysEqual Weight$23+12.7%
Jun 17, 2026ResumedRRaymond JamesMkt Perform
Jun 11, 2026DowngradeMMorgan StanleyOverweight → Equal-Weight$22+7.8%
May 11, 2026DowngradeEEvercore ISIOutperform → In-line$21+2.9%
Apr 20, 2026InitiatedUUBSNeutral$17-16.7%
Feb 05, 2026DowngradeAArgusBuy → Hold
Jan 09, 2026InitiatedGGoldmanNeutral$17-16.7%
Dec 16, 2025DowngradeJJefferiesBuy → Hold$17-16.7%
Oct 01, 2025InitiatedCCantor FitzgeraldNeutral$20-2.0%
Sep 15, 2025UpgradeRRaymond JamesMkt Perform → Outperform$20-2.0%

Peers

Mkt cap
TickerCompanyMkt cap
VTRVentas Inc48.97B
HRHealthcare Realty Trust Inc6.55B
WELLWelltower Inc180.47B
AREAlexandria Real Estate Equities Inc7.77B
AHRAmerican Healthcare REIT Inc14.25B
CHCTCommunity Healthcare Trust Inc438.85M
OHIOmega Healthcare Investors Inc14.91B
UHTUniversal Health Realty Income Trust538.75M
SBRASabra Healthcare REIT Inc5.59B
NHINational Health Investors Inc3.33B

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Patadia Ankit B.EVP and TreasurerNov 09 '26Sale20.786,115127,0702,838Nov 09 06:38 PM
Patadia Ankit B.OfficerNov 09 '26Proposed Sale20.786,115127,041Nov 09 04:54 PM
Bohn Scott RCDO and Head of LabMay 12 '26Sale19.4510,989213,7407,636May 13 04:30 PM
Bohn Scott ROfficerMay 12 '26Proposed Sale19.4510,989213,741May 12 04:07 PM

Held by

AUM
TickerCompanyAUM
VNQVanguard Real Estate Index Fund ETFAUM: 38.99B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
BKGIBNY Mellon Global Infrastructure Income ETFAUM: 1.97B
XLREState Street Real Estate Select Sector SPDR ETFAUM: 8.46B

News

latest 14 of 206
  • Healthpeak Edges Consensus But Misses The Whisper As Lab Leasing Inflects And 2027 Refinancing Clouds The Outlook (Earnings Whispers)
  • Healthpeak: Q3 Earnings Snapshot (Associated Press)
  • Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance (Business Wire)
  • Healthpeak's Lab Recovery Faces A Proof Test As Shares Lag Its Guidance Raises (Earnings Whispers)
  • Better High-Yield Dividend Stock: Pfizer vs. Healthpeak (TIKR)
  • Loading…
  • Better High-Yield Dividend Stock: Realty Income vs. Healthpeak (TIKR)
  • Better High-Yield Dividend Stock: Crown Castle vs. Healthpeak (TIKR)
  • Better High-Yield Dividend Stock: VICI Properties vs. Healthpeak (TIKR)
  • Better High-Yield Dividend Stock: Omega Healthcare vs. Healthpeak (TIKR)
  • Better High-Yield Dividend Stock: W. P. Carey vs. Healthpeak (TIKR)
  • Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast (Business Wire)
  • Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026 (Business Wire)
  • Vital Signs Strong For This High-Yield Healthcare REIT (Investor's Business Daily)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-020.0200.0640.020813.69739.186
2026Q22026-08-040.0800.0280.076749.81725.645
2026Q12026-05-050.2800.0530.278738.78694.593
2025Q42026-02-020.1600.0700.164704.78691.656
2025Q32025-10-23-0.1700.059-0.169690.34686.887
2025Q22025-07-240.0500.0640.045694.35689.326
2025Q12025-04-240.0600.0540.061702.89683.236
2024Q42025-02-030.0100.0480.006697.99688.877
2024Q32024-10-240.1200.0710.122700.4682.517
2024Q22024-07-250.2100.1000.208695.5665.116
2024Q12024-04-250.0100.0230.011606.56589.286
2023Q42024-02-080.1300.1040.129553.65553.777
2023Q32023-10-300.1200.0830.117556.24543.579
2023Q22023-07-270.0900.1080.095545.43535.677
2023Q12023-05-040.0400.0450.215134.341326
2022Q42023-02-220.0500.0380.003132.57129.916

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY0.3000.2942.226422.55419.79
2019FY0.3900.2580.043415.28414.2
2020FY0.3200.310-0.092437.51437.35
2021FY0.3900.3250.162457.7461.73
2022FY0.9201.0050.9212,0612,041
2023FY0.5600.5260.5562,1812,171
2024FY0.3600.3960.3592,7002,668
2025FY0.1000.0080.1002,7612,757
2026FY-0.431--3,011
2027FY-0.177--3,107
2028FY-0.261--3,295
2029FY-0.260--3,847

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06420762.23737.22805.3
2026Q4S2026-11-05520769.91737.22805.3
2026Q4S2026-11-03621761.87721.7805.3
2026Q4S2026-11-02611749.89721.7800.6
2026Q4S2026-10-31611749.89721.7800.6
2026Q4S2026-10-24621749.89721.7800.6
2026Q4S2026-10-21631749.89721.7800.6
2026Q4S2026-10-16632749.89721.7800.6
2026Q4S2026-10-07732758.32721.7808.89
2026Q4S2026-10-05722757.18721.7808.89
2026Q4S2026-09-20731758.33729.7808.89
2026Q4S2026-09-15831751.03699.95808.89
2026Q4S2026-09-08841751.03699.95808.89
2026Q4S2026-08-31841750.21699.95808.89

Estimate history

EPS, annual0.8812.2260.043-0.0920.1620.9210.5560.3590.1010.5433
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1220.0060.0610.045-0.1690.1640.2780.0760.025
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1847.6381846.0531240.3391644.8751896.1842061.1782181.0032700.4492822.5123064.82
Period201720182019202020212022202320242025TTM
Sales, quarterly700.397697.988702.889694.348705.873719.402752.952771.579820.892
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual469.436477.496505.222538.405539.097546.642547.156699.485695.037689.536
Period201720182019202020212022202320242025MRQ
Shares, quarterly699.405699.485699.485694.916694.946695.037695.263689.465689.536
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,064.822,822.512,700.452,181.002,061.181,896.181,644.881,240.341,846.05
Total Expenses2,547.952,277.492,239.211,741.491,711.601,579.031,472.64951.111,405.86
Operating Income516.88545.02461.24439.51349.58317.16172.24289.23440.19
Unusual Expense-47.5625.52145.6917.33-1.91226.25-124.94-105.6754.93
Net Income Before Taxes414.32284.29273.17314.94507.13128.37217.68176.321,058.21
Income Taxes6.179.284.35-9.62-4.42-3.26-9.42-5.48-17.85
Consolidated Net Income420.81100.19266.55333.03512.23549.18618.24173.931,070.81
Net Income From Continuing Operations377.1270.51242.38304.28496.25531.33603.84159.371,058.42
Net Income377.1270.51242.38304.28496.4587.55-49.0043.961,058.42
EPS (Recurring)0.500.130.510.580.920.46-0.26-0.062.32
EPS (Basic, Before Extraordinaries)0.540.100.360.560.920.16-0.090.042.25
EPS (Diluted)0.540.100.360.560.920.16-0.090.042.23
Non-Operating Income (Expense)193.9969.97238.0493.09328.58195.44138.84-0.97939.30
Other After Tax Adjustments-0.56-0.83-0.76-1.73-2.66-3.27-2.42-1.54-2.67
Stock Option Compensation Expense-15.8015.802.3424.8216.6814.9918.1613.08
Price To Earnings Ratio37.5737.5743.3546.1126.51222.64-381.7312.62
Price To Sales Ratio4.493.975.084.976.5610.269.7513.607.19
Gross Margin19.7922.4821.0524.2623.6623.1318.7532.2432.08
Operating Margin16.8619.3117.0820.1516.9616.7310.4723.3223.84
Net Margin12.302.508.9813.9524.094.62-2.983.5457.33
Shares Outstanding689.54695.04699.49547.16546.64539.10538.41505.22477.50
Market Capitalization14,073.5914,073.5914,177.7110,832.0713,476.1319,455.1116,274.6517,061.0613,399.00

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue820.89771.58752.95719.40705.87694.35702.89697.99
Total Expenses701.69637.55635.91572.79574.09566.36564.25574.06
Operating Income119.20134.03117.04146.61131.78127.99138.64123.93
Unusual Expense9.749.17-67.450.980.6514.131.3123.57
Net Income Before Taxes34.2359.33195.65125.1165.2439.6554.29-3.23
Income Taxes1.29-1.400.256.03-1.212.382.08-14.01
Consolidated Net Income36.5463.09199.51121.67-109.9838.9049.6010.52
Net Income From Continuing Operations17.1252.67193.48113.85-117.2631.5642.364.40
Net Income17.1252.67193.48113.85-117.2631.5642.364.40
EPS (Recurring)0.030.090.210.16-0.170.060.060.03
EPS (Basic, Before Extraordinaries)0.020.080.280.16-0.170.050.060.01
EPS (Diluted)0.020.080.280.16-0.170.050.060.01
Non-Operating Income (Expense)8.6726.7598.4560.1110.890.86-10.35-33.09
Other After Tax Adjustments-0.14-0.15-0.15-0.12-0.13-0.12-0.46-0.15
Stock Option Compensation Expense3.49-3.567.583.201.37--
Price To Earnings Ratio37.5767.13162.51-81.5944.1358.2743.35
Price To Sales Ratio4.495.003.983.964.754.355.055.25
Gross Margin17.3720.1018.5123.5621.4821.9322.9320.99
Operating Margin14.5217.3715.5420.3818.6718.4319.7217.76
Net Margin2.096.8325.7015.83-16.614.546.030.63
Shares Outstanding689.54689.47695.26695.04694.95694.92699.49699.49
Market Capitalization14,073.5914,753.5911,419.5711,174.8013,307.7812,164.7614,125.6114,177.71

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments537.70184.31169.02126.83211.74111.4393.78139.8582.20
Short Term Receivables1,057.351,132.00274.27428.27464.50237.64235.42111.17354.06
Investments16,104.7215,866.5213,049.7213,023.4812,712.5311,164.468,315.2310,923.2711,446.23
Investment in Unconsolidated Affiliates802.60936.81782.85706.68403.63402.87774.38540.09800.84
Net Property, Plant & Equipment412.20424.17240.16237.32233.94192.35167.320.000.00
Deferred Tax Assets222.50115.09113.5998.9892.9887.1972.6253.7242.09
Other Intangible Assets1,198.951,279.351,069.241,149.661,138.193,724.144,374.15950.461,363.04
Total Assets20,336.0219,938.2615,698.8515,771.2315,257.5215,920.0914,032.8912,718.5514,088.46
Total Debt10,317.859,215.157,210.426,862.326,551.776,622.076,229.645,622.577,933.05
Long Term Debt9,301.808,386.217,186.456,772.236,546.726,622.076,229.645,619.017,929.53
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1,715.721,665.481,563.561,620.631,559.651,950.671,135.77583.39560.48
Total Liabilities12,033.5710,880.638,773.988,482.958,111.418,572.747,365.426,205.968,493.52
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,500.098,401.286,350.456,654.706,515.476,733.726,085.065,944.445,301.01
Total Shareholders Equity7,500.098,401.286,350.456,654.706,515.476,733.726,085.065,944.445,301.01
Accumulated Minority Interest802.36656.35574.42633.58630.63613.62582.42568.15293.93
Total Equity8,302.459,057.626,924.877,288.287,146.107,347.356,667.476,512.595,594.94
Total Liabilities & Stockholders Equity20,336.0219,938.2615,698.8515,771.2315,257.5215,920.0914,032.8912,718.5514,088.46
Book Value Per Share10.7912.0111.6112.1712.0912.5112.0412.4511.29
Tangible Book Value Per Share9.7510.7711.0011.3811.0911.5111.5311.8110.42
Full-Time Employees411387193199196217204201190
Price to Book Ratio1.791.661.682.082.992.402.862.242.21
Return on Assets0.351.361.933.203.414.031.197.902.77
Return on Equity0.893.294.687.547.999.422.6518.827.61
Return on Invested Capital0.421.442.253.713.853.080.369.153.12
Quick Ratio1.661.6472.406.4235.497.169.850.912.04
Current Ratio1.661.6472.406.4235.497.169.850.912.04

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Funds from Operations1,155.711,174.721,048.63893.94793.92806.49668.21851.26828.87
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital143.66105.7544.7782.94118.8626.39108.7821.8946.31
Cash from Operating Activities1,299.371,280.461,093.40976.88912.78832.89776.99873.14875.18
Capital Expenditures-161.50-133.95-115.78-113.60-108.51-111.48-94.12-108.84-106.19
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses3,110.0013.120.010.491.390.640.00388.09299.67
Purchase or Sale of Investments-2,873.73-949.27149.58-508.78-781.80604.87-539.76-1,731.141,909.00
Purchase of Investments-3,916.33-1,435.29-718.07-855.29-1,071.66-2,136.67-2,046.90-2,325.61-1,013.21
Sale Or Maturity of Investments1,042.60486.02867.65346.52289.862,741.541,507.14594.472,922.21
Other Uses0.000.00-179.220.000.000.00-394.180.000.00
Other Sources21.8020.048.7124.981.450.001.809.360.00
Cash from Investing Activities96.56-1,050.05-136.69-596.90-887.47494.03-1,026.26-1,442.532,102.47
Cash Dividends Paid-844.40-849.10-794.78-657.02-649.36-650.08-787.07-720.12-696.91
Change in Capital Stock-100.11-96.00-190.37-6.25240.26-7.801,058.35790.54214.22
Repurchase of Common Pref Stock-101.75-97.14-190.69-6.52-67.84-12.84-10.53-5.04-3.43
Sale of Common Pref Stock1.641.150.320.28308.105.041,068.88795.59217.66
Proceedsfrom Stock Options1.641.150.320.28308.105.041,068.88795.59217.66
Issuance or Reduction of Debt, Net225.661,108.68153.22378.08324.58-301.0163.00653.67-2,313.11
Change in Long Term Debt225.661,108.68153.22378.08324.58-301.0163.00653.67-2,313.11
Issuance of Long Term Debt24,180.2713,108.334,491.2511,088.4816,382.1517,909.995,337.359,904.862,046.59
Reduction of Long Term Debt-23,954.61-11,999.65-4,338.03-10,710.40-16,057.57-18,211.00-5,274.35-9,251.19-4,359.69
Net Financing Active Other Cash Flow-230.99-40.60-109.49-52.60-34.72-330.26-87.82-110.14-124.41
Other Financing Activities Uses-222.20-37.87-89.71-45.28-30.55-93.31-40.61-29.52-124.41
Cash from Financing Activities-949.84122.99-941.43-337.79-117.92-1,289.16246.45613.95-2,920.20
Exchange Rate Effect----0.000.00-0.150.240.19
Net Change in Cash446.09353.4015.2842.19-92.6137.76-2.9744.8157.64
Free Cash Flow1,137.861,146.51977.62863.29804.27721.41682.87764.30768.99
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow46.9237.6374.9752.5387.26272.85-381.80184.22

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments605.821,718.681,265.91537.70159.73163.28
Short Term Receivables765.15795.531,175.121,057.351,122.351,139.27
Investments18,518.5116,877.6916,842.8916,104.7215,838.9215,829.98
Investment in Unconsolidated Affiliates466.11526.78530.35802.60796.17963.38
Net Property, Plant & Equipment393.38395.12395.93412.20417.37426.63
Deferred Tax Assets121.66122.32120.31222.50--
Other Intangible Assets1,541.341,243.911,285.721,198.951,247.871,287.73
Total Assets22,411.9721,680.0521,616.2220,336.0219,582.4019,810.27
Total Debt9,670.7310,320.3810,712.8610,317.859,432.869,351.35
Long Term Debt9,570.519,569.939,820.099,301.809,431.929,349.50
Provision for Risks Charges0.000.000.000.000.200.00
Other Liabilities1,935.901,861.231,843.351,715.721,884.031,871.97
Total Liabilities11,606.6312,181.6112,556.2112,033.5711,317.1011,223.33
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,865.947,844.757,826.297,500.097,597.277,928.10
Total Shareholders Equity7,865.947,844.757,826.297,500.097,597.277,928.10
Accumulated Minority Interest2,939.411,653.691,233.72802.36668.03658.84
Total Equity10,805.349,498.449,060.018,302.458,265.308,586.94
Total Liabilities & Stockholders Equity22,411.9721,680.0521,616.2220,336.0219,582.4019,810.27
Book Value Per Share11.4111.3811.2610.7910.9311.41
Tangible Book Value Per Share9.9810.2410.079.759.9810.36
Full-Time Employees---411--
Price to Book Ratio1.791.901.521.471.681.50
Return on Assets1.801.171.070.35-0.200.82
Return on Equity4.883.082.770.89-0.481.97
Return on Invested Capital0.100.301.100.68-0.690.18
Quick Ratio14.013.402.781.66101.40440.03
Current Ratio14.013.402.781.66101.40440.03

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations303.35289.03272.61290.72290.73289.85
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital58.2979.10-2.859.1231.4381.71
Cash from Operating Activities361.64368.13269.75299.84322.16371.56
Capital Expenditures-37.62-42.10-23.96-57.83-27.26-25.73
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses1,516.72691.96901.330.007.155.97
Purchase or Sale of Investments-2,042.56160.57-630.36-361.38-178.55-193.89
Purchase of Investments-2,042.31-294.83-888.56-690.63-262.94-202.13
Sale Or Maturity of Investments-0.26455.40258.20329.2584.398.23
Other Uses0.000.000.000.000.000.00
Other Sources0.007.136.847.8310.541.29
Cash from Investing Activities-563.46817.56253.85-411.38-188.12-212.36
Cash Dividends Paid-210.29-210.26-211.99-211.86-211.87-211.88
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.04-99.55-1.280.760.12-71.97
Repurchase of Common Pref Stock-0.10-100.19-1.37-0.09-0.02-72.08
Sale of Common Pref Stock0.060.640.100.840.130.11
Proceedsfrom Stock Options0.060.640.100.840.130.11
Issuance or Reduction of Debt, Net-656.72-397.74570.33709.7884.97158.29
Change in Long Term Debt-656.72-397.74570.33709.7884.97158.29
Issuance of Long Term Debt7,753.007,854.205,887.652,685.423,194.762,454.65
Reduction of Long Term Debt-8,409.72-8,251.94-5,317.32-1,975.63-3,109.79-2,296.36
Net Financing Active Other Cash Flow-43.99-25.37-152.45-9.17-10.80-8.96
Other Financing Activities Uses-40.13-24.31-148.71-9.05-9.66-8.96
Cash from Financing Activities-911.04-732.91204.61489.51-137.58-134.52
Net Change in Cash-1,112.86452.78728.21377.97-3.5524.67
Free Cash Flow324.02326.03245.80242.02294.90345.83
Price to Free Cash Flow46.9256.1940.6637.5743.6839.15

Revenue breakdown

United States2024: 2.70B 2025: 2.82B
Consolidation, Policy2024: 65.86M 2025: 85.00M
Lab2024: 881.45M 2025: 860.02M
Outpatient Medical2024: 1.18B 2025: 1.27B
Senior Housing2024: 568.48M 2025: 603.99M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.32%22.9M687.4M5.42M
2026-10-153.16%21.7M687.4M5.51M
2026-09-303.39%23.3M687.4M5.43M
2026-09-153.69%25.4M687.4M5.65M
2026-08-313.52%24.2M687.4M6.12M
2026-08-143.27%22.5M687.3M7.43M
2026-07-313.55%24.4M687.3M8.26M
2026-07-153.49%24.0M687.2M8.57M
2026-06-303.95%27.1M687.2M9.00M
2026-06-154.03%27.6M686.8M9.18M
2026-05-294.04%27.8M687.3M9.05M
2026-05-154.73%32.5M687.3M8.63M
2026-04-304.68%32.2M687.3M8.76M
2026-04-154.62%32.0M693.2M9.05M
2026-03-314.78%33.1M692.4M9.32M
2026-03-134.30%29.7M692.2M9.00M
2026-02-274.63%32.1M692.2M9.22M
2026-02-134.51%31.2M692.2M8.75M
2026-01-303.95%27.3M692.7M7.98M
2026-01-153.70%25.6M692.7M8.03M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.507.108.606.623.0970.000.000.962-0.0230.003
call15.004.706.005.662.0873.000.000.888-0.0540.006
call17.502.303.502.051.34255.000.000.830-0.0450.008
call20.000.500.700.630.3591,81537.000.634-0.0240.013
call22.500.000.050.030.41755.000.000.081-0.0110.005
call25.000.000.050.000.6690.000.000.052-0.0120.004
call30.000.000.750.001.2170.000.000.033-0.0150.002
put12.500.000.100.001.8200.000.00-0.037-0.0250.003
put15.000.000.750.031.7321.000.00-0.110-0.0560.006
put17.500.000.350.051.0731,1840.00-0.168-0.0460.008
put20.000.000.350.200.4011370.00-0.361-0.0250.013
put22.501.852.600.000.9190.000.00-0.917-0.0110.005
put25.003.905.300.001.5730.000.00-0.947-0.0140.004
put30.008.9010.400.002.3830.000.00-0.965-0.0150.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-08-07SCHEDULE 13GSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-22SCHEDULE 13G/ASEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-14SCHEDULE 13GSEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-13SCHEDULE 13GSEC
2026-05-12144Filing for proposed sale of securities under Rule 144.SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-048-KCurrent report2026-04-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100127.07K1
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500213.74K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HUNTINGTON NATIONAL BANK0.00%

Funds

Fund% owned
PGIM Ultra Short Bond ETF15.67%
TCW METWEST TOTAL RETURN BOND FUND4.03%
VANGUARD REAL ESTATE INDEX FUND3.84%
Undiscovered Managers Behavioral Value Fund3.25%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
VANGUARD SMALL-CAP INDEX FUND2.29%
VANGUARD SMALL-CAP VALUE INDEX FUND1.45%
iShares Core S&P 500 ETF1.38%
Invesco S&P 500 Equal Weight ETF1.32%

OakChart. DOC. Cached 15 minutes.